دوره 7، شماره 2 - ( 6-1402 )
جلد 7 شماره 2 صفحات 7-5 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rasheed F, Karamchedu S, Bagadi V H C, Misbah T, Punjala M G, Nightingale F et al . A clinico-immunohistopathological study of urothelial neoplasms with an expression of HER2/Neu and Ki-67 in malignant lesions presenting to a tertiary centre. jcbr 2023; 7 (2) :5-7
URL: http://jcbr.goums.ac.ir/article-1-422-fa.html
URL: http://jcbr.goums.ac.ir/article-1-422-fa.html
A clinico-immunohistopathological study of urothelial neoplasms with an expression of HER2/Neu and Ki-67 in malignant lesions presenting to a tertiary centre. Journal of Clinical and Basic Research. 1402; 7 (2) :5-7
چکیده: (1123 مشاهده)
Background: HER2/neu is associated with increased tumor grade, and Ki-67 is related to tumor recurrence and stage progression. This study aims to evaluate the clinical profile in patients with urothelial neoplasms and correlate the expression of HER2/neu and Ki-67 in urothelial carcinomas.
Methods: This is a five-year retrospective study from June 2017 to May 2022 with forty cases from the Department of Pathology. A microscopic examination was done to assess the tumor stage and histological grade. Immunohistochemistry was performed with HER2/neu and Ki-67.
Results: 65% (26/40) of the cases were diagnosed as infiltrating urothelial carcinoma, 30% (12) of the cases as low-grade non-invasive urothelial carcinoma, one case as a papillary urothelial neoplasm of low malignant potential (PUNLMP), and one case as urothelial papilloma. 95.5% of infiltrating carcinomas and 84.5% of low-grade non-invasive carcinomas were Ki-67-positive. A significant correlation was observed between the expression of Her-2/neu and Ki-67 and the 2016 World Health Organization (WHO) grading system of urothelial carcinoma. Moderate-to-strong HER2/neu overexpression (2+ or 3+) was observed in only 18% of cases.
Conclusion: The expression of ki-67 increased with an increase in the grade of tumor, which shows its prognostic importance. The relation between Ki-67 expression and the histologic grade of the tumor and the presence of lymphovascular invasion was significant. A significant correlation was observed between the grade of the carcinoma and the immunohistochemical expression of HER2/neu, in which 19.3% of high-grade carcinoma cases showed immunohistochemical expression of the HER2/neu marker. Further studies with a larger population group are required to establish the role of HER2/neu as a prognostic marker.
Methods: This is a five-year retrospective study from June 2017 to May 2022 with forty cases from the Department of Pathology. A microscopic examination was done to assess the tumor stage and histological grade. Immunohistochemistry was performed with HER2/neu and Ki-67.
Results: 65% (26/40) of the cases were diagnosed as infiltrating urothelial carcinoma, 30% (12) of the cases as low-grade non-invasive urothelial carcinoma, one case as a papillary urothelial neoplasm of low malignant potential (PUNLMP), and one case as urothelial papilloma. 95.5% of infiltrating carcinomas and 84.5% of low-grade non-invasive carcinomas were Ki-67-positive. A significant correlation was observed between the expression of Her-2/neu and Ki-67 and the 2016 World Health Organization (WHO) grading system of urothelial carcinoma. Moderate-to-strong HER2/neu overexpression (2+ or 3+) was observed in only 18% of cases.
Conclusion: The expression of ki-67 increased with an increase in the grade of tumor, which shows its prognostic importance. The relation between Ki-67 expression and the histologic grade of the tumor and the presence of lymphovascular invasion was significant. A significant correlation was observed between the grade of the carcinoma and the immunohistochemical expression of HER2/neu, in which 19.3% of high-grade carcinoma cases showed immunohistochemical expression of the HER2/neu marker. Further studies with a larger population group are required to establish the role of HER2/neu as a prognostic marker.
نوع مقاله: پژوهشي |
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0).